Orthofix to Fully Leverage Enabling Tech Under New Leadership

Orthofix reported 4Q23 orthopedic sales of $200.4 million, +64% compared to the fourth quarter of 2023. The company generated $746.6 million in orthopedic sales in 2023 and grew 62.1% compared to the prior year. On a pro forma basis, Orthofix grew +6.5% for both the fourth quarter and full year.

After a period of disruption, including the...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us